Saturday, September 16, 2017
|
|
|
| Welcome Address |
Tony Finelli/Munir Jamal |
VIEW |
| |
|
|
Localized Prostate Cancer
|
|
|
| Improving Screening for Prostate Cancer |
Arthur Grabowski |
VIEW |
| Active Surveillance |
Nathan Perlis |
VIEW |
| Focal Therapy |
Nathan Perlis |
VIEW |
| |
|
|
Localized and Advanced Prostate Cancer
|
|
|
| PET Scan and Molecular Imaging |
Robert Hamilton |
VIEW |
| Update on Radiation Therapy for Prostate Cancer |
Alejandro Berlin |
VIEW |
| |
|
|
Advanced Prostate Cancer
|
|
|
| Castrate-Sensitive Prostate Cancer |
Tony Finelli |
VIEW |
| Future Directions for the Management of mCRPC |
Neil Fleshner |
VIEW |
| |
|
|
Bladder Cancer
|
|
|
| Molecular Grading of Bladder Cancer: Ready for Clinical Practice |
Alexandre Zlotta |
VIEW |
| Trimodal Therapy for Bladder Cancer |
Alejandro Berlin |
VIEW |
| Neoadjuvant vs. Adjuvant Chemotherapy for Invasive Bladder Cancer |
Neil Fleshner |
VIEW |
| Neoadjuvant vs. Adjuvant Chemotherapy for Invasive Bladder Cancer |
Alexandre Zlotta |
VIEW |
| |
|
|
Kidney Cancer
|
|
|
| The Management of Complex Renal Cysts |
Michael Leveridge |
VIEW |
| Adjuvant Therapy Should be Offered to Patients at High-Risk for Recurrent RCC |
Anil Kapoor |
VIEW |
| Adjuvant Therapy Should be Offered to Patients at High-Risk for Recurrent RCC |
Aaron Hansen |
VIEW |
| Immuno-Oncology Primer for Urologists |
Aaron Hansen |
VIEW |
| Evaluation of the Incidentally Detected Adrenal Mass |
Munir Jamal |
VIEW |
| |
|
|
Sunday, September 17, 2017
|
|
|
| VTE Prophlaxis in GU Oncology |
Kamal Mattar |
VIEW |
| Social Media in Urology |
Michael Leveridge |
VIEW |
| Technology in Urology to Improve Patient-Centred Care |
Andrew Feifer |
VIEW |
| Update on GU Sarcoma |
Robert Hamilton |
VIEW |
